|
| 33630025 | Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors. | JAMA Oncol | 2021 |
| 31152158 | Publisher Correction: The long tail of oncogenic drivers in prostate cancer. | Nat Genet | 2019 |
| 31243372 | Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer. | Nature | 2019 |
| 29144510 | Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers. | Genet Med | 2018 |
| 32832831 | Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program. | JCO Precis Oncol | 2018 |
| 32832832 | Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors. | JCO Precis Oncol | 2018 |
| 29941307 | Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma. | Eur Urol | 2018 |
| 29906450 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. | Cell | 2018 |
| 29899824 | Clinical validation of the Tempus xO assay. | Oncotarget | 2018 |
| 30291535 | Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer. | Med Oncol | 2018 |
| 29610475 | The long tail of oncogenic drivers in prostate cancer. | Nat Genet | 2018 |
| 29572239 | Identification of novel <i>MECOM</i> gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review. | Cold Spring Harb Mol Case Stud | 2018 |
| 29744932 | Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer. | Prostate | 2018 |
| 29261439 | Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. | J Clin Oncol | 2018 |
| 29233927 | Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms. | Cancer Res | 2018 |
| 27550065 | Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer. | Prostate | 2017 |
| 29163793 | Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy. | Oncotarget | 2017 |
| 28783718 | Integrative clinical genomics of metastatic cancer. | Nature | 2017 |
| 28751446 | Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification. | Clin Cancer Res | 2017 |
| 28860053 | Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors. | Transl Res | 2017 |
| 25985884 | Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. | Eur Urol | 2016 |
| 27604489 | Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney. | Cancer Discov | 2016 |
| 27433846 | Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. | N Engl J Med | 2016 |
| 26000489 | Integrative clinical genomics of advanced prostate cancer. | Cell | 2015 |
| 28843286 | Integrative Clinical Genomics of Advanced Prostate Cancer. | Cell | 2015 |
| 26253700 | The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing. | Genome Res | 2015 |
| 26325560 | Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. | JAMA | 2015 |
| 24389164 | Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. | Am J Pathol | 2014 |
| 25115393 | The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression. | Oncotarget | 2014 |
| 23313952 | Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. | Nat Genet | 2013 |
| 24185510 | Activating ESR1 mutations in hormone-resistant metastatic breast cancer. | Nat Genet | 2013 |
| 23558953 | Identification of targetable FGFR gene fusions in diverse cancers. | Cancer Discov | 2013 |
| 23159737 | Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. | Mol Cell | 2013 |
| 22415461 | Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models. | Prostate | 2012 |
| 23097625 | Role of transcriptional corepressor CtBP1 in prostate cancer progression. | Neoplasia | 2012 |
| 22726445 | Expressed pseudogenes in the transcriptional landscape of human cancers. | Cell | 2012 |
| 22722839 | The mutational landscape of lethal castration-resistant prostate cancer. | Nature | 2012 |
| 22287547 | PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma. | Cancer Res | 2012 |
| 21676887 | TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. | Cancer Res | 2011 |
| 22133722 | Personalized oncology through integrative high-throughput sequencing: a pilot study. | Sci Transl Med | 2011 |
| 22131877 | Detection of somatic copy number alterations in cancer using targeted exome capture sequencing. | Neoplasia | 2011 |
| 22101766 | Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. | Nat Med | 2011 |
| 21840484 | Coordinated regulation of polycomb group complexes through microRNAs in cancer. | Cancer Cell | 2011 |
| 21813756 | Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. | Sci Transl Med | 2011 |
| 21555375 | Characterization of bone metastases from rapid autopsies of prostate cancer patients. | Clin Cancer Res | 2011 |
| 21575865 | Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. | Cancer Cell | 2011 |
| 20622896 | The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. | Oncogene | 2010 |
| 20478527 | An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. | Cancer Cell | 2010 |
| 20537788 | Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8. | Eur Urol | 2010 |
| 19212411 | Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. | Nature | 2009 |